WAM
OGN icon

Wakefield Asset Management’s Organon & Co OGN Stock Holding History

Wakefield Asset Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,646
Closed -$289K – 177
2023
Q3 		$289K Buy
+16,646
New +$347K 0.13% 142

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Wakefield Asset Management's OGN Position: Q4 2023 in Review

Wakefield Asset Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 16,646 shares — an estimated $289K sold.

Wakefield Asset Management first reported a position in OGN in Q3 2023 and held it in 1 quarter. The position peaked at $289K in Q3 2023. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Wakefield Asset Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Wakefield Asset Management sold 16,646 Organon & Co shares in Q4 2023, an estimated $289K.
  • Wakefield Asset Management first reported a position in Organon & Co in Q3 2023 and held it in 1 quarter.
  • Wakefield Asset Management's Organon & Co position peaked at $289K in Q3 2023.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Wakefield Asset Management's 13F filing for Q4 2023, filed 25 Jan 2024.